statistiche ricercatore

Continente	#
NA - Nord America	888
EU - Europa	785
AS - Asia	388
SA - Sud America	56
Continente sconosciuto - Info sul continente non disponibili	30
AF - Africa	7
OC - Oceania	6
Totale	2.160

Nome	#
Chronic resveratrol treatment inhibits MRC5 fibroblast SASP-related pro-tumoral effects on melanoma cells	383
Modulation of the Senescence-Associated Inflammatory Phenotype in Human Fibroblasts by Olive Phenols	287
Oleuropein aglycone attenuates the pro-angiogenic phenotype of senescent fibroblasts: a functional study in endothelial cells	264
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8	221
Serpin A1 and the modulation of type I collagen turnover: effect of the C-terminal peptide 409-418 (SA1-III) in human dermal fibroblasts	204
SASP-LIKE PHENOTYPE IN ALZHEIMER CELLULAR MODELS: MODULATION BY NATURAL PHENOLIC COMPOUNDS	180
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent-Associated Secretory Phenotype" on endothelial colony-forming cells: The role of IL8	178
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells	172
Chronic treatment with resveratrol and olive oil phenols on MRC5 fibroblast SASP: inhibition of pro-tumoral microenvironment	171
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC	60
Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma	40
Totale	2.160

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	73	2	8	5	7	7	2	2	6	2	6	10	16
2022/2023	195	14	30	11	11	11	34	25	16	30	3	2	8
2023/2024	76	2	8	9	2	9	6	5	16	0	3	7	9
2024/2025	513	29	46	32	71	150	73	4	32	33	13	21	9
2025/2026	658	67	88	42	48	71	35	83	34	61	46	23	60
2026/2027	32	32	0	0	0	0	0	0	0	0	0	0	0
Totale													2.160